aspirin has been researched along with Hyperlipoproteinemia Type II in 6 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The patient has been treated with statin, ezetimibe, aspirin, and traditional heart failure (HF) medications." | 3.88 | Early severe coronary heart disease and ischemic heart failure in homozygous familial hypercholesterolemia: A case report. ( Kuang, H; Li, L; Lu, T; Shou, W; Yi, Q; Zhou, X, 2018) |
| "The rheumatic manifestations of familial hypercholesterolemia include recurrent Achilles pain or tendinitis, acute mono/oligoarthritis and migratory (rheumatic fever-like) polyarthritis." | 1.28 | Hypercholesterolemic (type II hyperlipoproteinemic) arthritis. ( Cohen, L; Rimon, D, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuang, H | 1 |
| Zhou, X | 1 |
| Li, L | 1 |
| Yi, Q | 1 |
| Shou, W | 1 |
| Lu, T | 1 |
| Shires, R | 1 |
| Chetty, N | 1 |
| Baker, SG | 1 |
| Bradlow, BA | 1 |
| Rimon, D | 1 |
| Cohen, L | 1 |
| Cerbone, AM | 1 |
| Di Minno, G | 1 |
| Postiglione, A | 1 |
| Cirillo, F | 1 |
| Pannain, M | 1 |
| Mattioli, PL | 1 |
| Mancini, M | 1 |
| Zucker, ML | 1 |
| Trowbridge, C | 1 |
| Woodroof, J | 1 |
| Chernoff, SB | 1 |
| Reynoso, L | 1 |
| Dujovne, CA | 1 |
1 review available for aspirin and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Royal College of Physicians of Edinburgh Consensus Conference on lipid lowering to prevent vascular events 17 & 18 March 1999.
Topics: Adult; Aged; Aspirin; Cholesterol; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis | 1999 |
2 trials available for aspirin and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
The effect of low-dose aspirin and platelet aggregation in familial hypercholesterolaemia.
Topics: Adult; Aspirin; Clinical Trials as Topic; Female; Humans; Hyperlipoproteinemia Type II; Male; Platel | 1983 |
Low- vs high-dose aspirin. Effects on platelet function in hyperlipoproteinemic and normal subjects.
Topics: Adult; Aspirin; Bleeding Time; Blood Platelets; Epoprostenol; Female; Humans; Hyperlipoproteinemia T | 1986 |
3 other studies available for aspirin and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Early severe coronary heart disease and ischemic heart failure in homozygous familial hypercholesterolemia: A case report.
Topics: Adolescent; Anticholesteremic Agents; Aspirin; Coronary Disease; Ezetimibe; Female; Heart Failure; H | 2018 |
Hypercholesterolemic (type II hyperlipoproteinemic) arthritis.
Topics: Adult; Arthritis; Aspirin; Humans; Hyperlipoproteinemia Type II; Male; Xanthomatosis | 1989 |
Thromboxane- and ADP-independent aggregation and exposure of fibrinogen receptors on platelets from patients with familial hypercholesterolemia.
Topics: Adenosine Diphosphate; Adolescent; Adult; Apyrase; Aspirin; Child; Female; Humans; Hyperlipoproteine | 1985 |